Results 1 to 10 of about 1,135 (159)

Extraction Optimization of Astragaloside IV by Response Surface Methodology and Evaluation of Its Stability during Sterilization and Storage

open access: yesMolecules, 2021
Radix Astragali is referred to as a variety of food-medicine herb, and it is commonly applied as Traditional Chinese Medicine (TCM). However, it is extremely difficult to extract its bio-active compounds (astragaloside IV) and apply it in food processing
Lin Xu, Lianfu Zhang, Xu Lin
exaly   +4 more sources

Astragaloside IV Inhibits Adipose Lipolysis and Reduces Hepatic Glucose Production via Akt Dependent PDE3B Expression in HFD-Fed Mice

open access: yesFrontiers in Physiology, 2018
Objective: This study aims to investigate the effect of astragaloside IV on adipose lipolysis and hepatic gluconeogenesis.Methods: High-fat diet (HFD) feeding induced adipose dysfunction with enhanced endogenous glucose production in mice. The effects of
Qun Du, Aiyun Li, Imran Shair Mohammad
exaly   +4 more sources

Astragaloside IV protects RGC-5 cells against oxidative stress

open access: yesNeural Regeneration Research, 2018
Astragaloside IV is the main active compound of Astragalus membranaceus. Astragaloside IV has strong anti-oxidative activities and protective effects against progression of peripheral neuropathy.
Ming Hao   +4 more
doaj   +2 more sources

Pharmacokinetic study on the co-administration of abemaciclib and astragaloside IV in rats

open access: yesPharmaceutical Biology, 2022
Context The co-administration of abemaciclib and astragaloside IV might occur in the treatment of breast cancer.Objective This study evaluates the interaction between abemaciclib and astragaloside IV in rats and describes the potential mechanism ...
Sen Sun, Lu Liu, Hongming Song, Hong Li
doaj   +3 more sources

Network Pharmacology-Based Investigation on the Anti-Osteoporosis Mechanism of Astragaloside IV

open access: yesNatural Product Communications, 2021
Astragaloside IV is the main active ingredient of Astragalus membranaceus . Studies have found that it can promote the proliferation of osteoblasts and can antagonize the apoptosis of mouse osteoblasts induced by hydrogen peroxide, but its molecular ...
Li Ou   +6 more
doaj   +1 more source

Astragalus Ⅳ ameliorates the dry eye injury in rabbit model via MUC1-ErbB1 pathway

open access: yesEuropean Journal of Histochemistry, 2021
The therapeutic effects and potential mechanisms of astragaloside IV on a rabbits dry eye model induced by benzalkonium chloride (BAC) was examined. In our study, a BAC-induced dry eye rabbit model was treated with eye drops containing astragaloside IV ...
Li Chu   +3 more
doaj   +1 more source

Biotechnological approaches for sustainable production of astragaloside I, II and IV from endemic species of Astracantha aitosensis (Ivan.) and Astragalus membranaceus (fisch.) by in vitro cultures [PDF]

open access: yesPharmacia, 2023
This study investigates the bioproduction of astragalosides I, II and IV from endemic Astracantha aitosensis (arnacantha) and Astragalus membranaceus species, and the biotechnological methods for increased efficiency.
Preslav Enchev   +2 more
doaj   +3 more sources

Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway

open access: yesBrazilian Journal of Medical and Biological Research, 2023
Astragaloside IV is a biologically active substance derived from the traditional Chinese medicine Astragalus mambranaceus Bunge, and has antioxidant, anti-inflammatory, and anti-apoptotic properties.
Lei Li   +8 more
doaj   +1 more source

Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism

open access: yesPharmaceutical Biology, 2020
Context Puerarin and astragaloside IV (AS-IV) are sometimes used together for the treatment of disease in Chinese clinics, however, the drug–drug interaction between puerarin and AS-IV is still unknown.
Huan Zhang   +4 more
doaj   +1 more source

Study on the liver Drug’s dominant metabolic enzymes for six effective components of the Huang qi Liuyi decoction

open access: yesFrontiers in Pharmacology, 2023
Objective: To investigate the dominant metabolic enzymes of six effective components (astragaloside IV, glycyrrhizic acid, calycosin-glucuronide, formononetin, ononin, calycosin-7-O-β-D- glucoside) of Huangqi Liuyi decoction extract (HQD).Methods: Mouse ...
Qun Wang   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy